The Role of Intestinal Inflammation in the Pathophysiology of IBS
肠道炎症在 IBS 病理生理学中的作用
基本信息
- 批准号:7135224
- 负责人:
- 金额:$ 15.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-25 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:clinical researchcytokinediarrheaenteric bacteriaenzyme linked immunosorbent assaygastrointestinal motility /pressurehuman subjectimmunologic assay /testinflammationintestinal mucosairritable bowel syndromemucosal immunitymuscle toneneuropeptidespatient oriented researchpolymerase chain reactionsmooth muscle
项目摘要
DESCRIPTION (provided by applicant):
This career development application has two components: I. A mentored research project, and II. Educational/training activities. Epidemiological studies have implicated intestinal inflammation and chronic activation of the immune system in the etiology of IBS for some patients. Recent research in animal models suggests that these factors can be involved in the pathophysiological mechanisms responsible for intestinal dysmotility and visceral hypersensitivity. However, the role of intestinal inflammation and mucosal immune activation has not been adequately and systematically investigated in patients with IBS. In the proposed research project we will compare sub-clinical mucosal inflammation between patients with diarrhea predominant IBS (D-IBS) and control. We will specifically look at pro- and anti-inflammatory cytokines and inflammatory-associated neuropeptides. Analyses will be performed by Real-time PCR and ELISA techniques to verify results. In our second aim we will investigate whether alterations in inflammatory markers are associated with alterations with relevant intestinal physiology including colonic pain thresholds, phasic motility, and smooth muscle tone. We will study 33 IBS patients with D-IBS and 33 healthy controls. Intestinal physiological data will be collected on the same study population of an NIH supported study on the heterogeneity of IBS (NIDDK Grant DK 31369, Whitehead PI) on which Dr. Whitehead is collaborating with Dr. Ringel. The educational/training components of this proposal have been developed with the advice of Dr. Ringel's mentors: Dr. Balfour Sartor is a world renowned expert and researcher in intestinal inflammation and Dr. William Whitehead is a world renowned expert and researcher in functional Gl disorders. We propose formal coursework as well as laboratory training aiming to expand and increase Dr. Ringel's knowledge and skills in theories and research methodologies in these areas. The overall goal is to establish Dr. Ringel as an independently-funded translational researcher. Thus, the methodologies, results and protocols that will be developed during the award will be used to design mechanistic intervention studies and as preliminary data for submission of future (NIH) grants.
描述(由申请人提供):
这个职业发展应用程序有两个组成部分:一。一个指导研究项目,和二。教育/培训活动。流行病学研究表明,肠道炎症和免疫系统的慢性激活与某些患者的IBS病因有关。最近的动物模型研究表明,这些因素可能参与了肠道动力障碍和内脏高敏感性的病理生理机制。然而,肠道炎症和粘膜免疫激活的作用还没有充分和系统地研究IBS患者。本研究拟比较腹泻型肠易激综合征(D-IBS)患者和对照组的亚临床黏膜炎症。我们将特别关注促炎和抗炎细胞因子以及炎症相关神经肽。将通过实时PCR和ELISA技术进行分析,以验证结果。在我们的第二个目标中,我们将研究炎症标志物的改变是否与相关肠道生理学的改变相关,包括结肠疼痛阈值,阶段性运动和平滑肌张力。我们将研究33例患有D-IBS的IBS患者和33名健康对照。将在NIH支持的IBS异质性研究(NIDDK Grant DK 31369,Whitehead PI)的同一研究人群中收集肠道生理数据,Whitehead博士与Ringel博士合作开展该研究。本提案的教育/培训部分是根据Ringel博士导师的建议制定的:Balfour Sartor博士是世界知名的肠道炎症专家和研究人员,William Whitehead博士是世界知名的功能性GI疾病专家和研究人员。我们提出正式的课程以及实验室培训,旨在扩大和增加林格尔博士在这些领域的理论和研究方法的知识和技能。总体目标是将Ringel博士确立为独立资助的翻译研究人员。因此,将在授予期间开发的方法,结果和协议将用于设计机制干预研究,并作为提交未来(NIH)赠款的初步数据。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YEHUDA RINGEL其他文献
YEHUDA RINGEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YEHUDA RINGEL', 18)}}的其他基金
Fecal Microflora in Irritable Bowel Syndrome: Characterization & Significance
肠易激综合症的粪便微生物群落:特征
- 批准号:
8072701 - 财政年份:2010
- 资助金额:
$ 15.72万 - 项目类别:
Fecal Microflora in Irritable Bowel Syndrome (IBS): Characterization and Signific
肠易激综合征 (IBS) 中的粪便微生物群落:特征和意义
- 批准号:
7896186 - 财政年份:2010
- 资助金额:
$ 15.72万 - 项目类别:
CLINICAL TRIAL: PROBIOTIC BACTERIA IN PATIENTS WITH IBS, FUNCTIONAL DIARRHEA, OR
临床试验:益生菌治疗肠易激综合症、功能性腹泻或
- 批准号:
7716794 - 财政年份:2008
- 资助金额:
$ 15.72万 - 项目类别:
YOGURT DRINK CONTAINING BIFIDOBACTERIUM LACTIS (BB12) FUNCTIONAL GASTROINTESTINL
含有乳双歧杆菌 (BB12) 功能性胃肠测试的酸奶饮料
- 批准号:
7716904 - 财政年份:2008
- 资助金额:
$ 15.72万 - 项目类别:
The Role of Intestinal Inflammation in the Pathophysiology of IBS
肠道炎症在 IBS 病理生理学中的作用
- 批准号:
7480910 - 财政年份:2006
- 资助金额:
$ 15.72万 - 项目类别:
ASSOCIATION BETWEEN INTESTINAL MICROFLORA AND MUCOSAL INFLAMMATION IN IBS
IBS 肠道菌群与粘膜炎症之间的关联
- 批准号:
7625661 - 财政年份:2006
- 资助金额:
$ 15.72万 - 项目类别:
The Role of Intestinal Inflammation in the Pathophysiology of IBS
肠道炎症在 IBS 病理生理学中的作用
- 批准号:
7920791 - 财政年份:2006
- 资助金额:
$ 15.72万 - 项目类别:
PROBIOTIC BACTERIA IN PATIENTS WITH IBS, FUNCTIONAL DIARRHEA, OR BLOATING
肠易激综合症、功能性腹泻或腹胀患者中的益生菌
- 批准号:
7625572 - 财政年份:2006
- 资助金额:
$ 15.72万 - 项目类别:
The Role of Intestinal Inflammation in the Pathophysiology of IBS
肠道炎症在 IBS 病理生理学中的作用
- 批准号:
7681542 - 财政年份:2006
- 资助金额:
$ 15.72万 - 项目类别:
ESOMEPRAZOLE IN PATIENTS WITH DIARRHEA PREDOMINANT IBS OR FUNCTIONAL DIARRHEA
埃索美拉唑治疗腹泻为主的肠易激综合征或功能性腹泻患者
- 批准号:
7377494 - 财政年份:2005
- 资助金额:
$ 15.72万 - 项目类别:
相似国自然基金
KCTD10对2型免疫反应(Th2)的调控研究
- 批准号:2020JJ4441
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
乙烯合酶ACS家族的AEF蛋白调节拟南芥开花时间的机制研究
- 批准号:31970735
- 批准年份:2019
- 资助金额:58.0 万元
- 项目类别:面上项目
USP13调控IL-18诱导的NF-κB活化的分子机制研究
- 批准号:31900556
- 批准年份:2019
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
let-7通过SOCS1调控巨噬细胞极化及其在前列腺癌进展中的作用
- 批准号:81560465
- 批准年份:2015
- 资助金额:38.0 万元
- 项目类别:地区科学基金项目
纳米微粒载NF-κB圈套基因对神经发育缺陷大鼠模型的干预研究
- 批准号:30870892
- 批准年份:2008
- 资助金额:8.0 万元
- 项目类别:面上项目
相似海外基金
Phosphodiesterase 4B Inhibition as a Therapeutic Target for Alcohol-associated Liver Disease
磷酸二酯酶 4B 抑制作为酒精相关性肝病的治疗靶点
- 批准号:
10354185 - 财政年份:2023
- 资助金额:
$ 15.72万 - 项目类别:
Microbiome targeted oral butyrate therapy in Gulf War multisymptom illness
微生物组靶向口服丁酸盐治疗海湾战争多症状疾病
- 批准号:
10367805 - 财政年份:2023
- 资助金额:
$ 15.72万 - 项目类别:
Dietary regulation of type 2 immunity and inflammation in the gut
肠道 2 型免疫和炎症的饮食调节
- 批准号:
10740269 - 财政年份:2023
- 资助金额:
$ 15.72万 - 项目类别:
Preclinical validation of small molecule immunomodulators for the treatment of Crohn's disease
小分子免疫调节剂治疗克罗恩病的临床前验证
- 批准号:
10600659 - 财政年份:2023
- 资助金额:
$ 15.72万 - 项目类别:
A Novel Immunological-Directed Biotherapy for Treating Rheumatoid Arthritis
治疗类风湿关节炎的新型免疫导向生物疗法
- 批准号:
10760183 - 财政年份:2023
- 资助金额:
$ 15.72万 - 项目类别:
Redefining C.difficile patient outcomes through network medicine
通过网络医学重新定义艰难梭菌患者的治疗结果
- 批准号:
10722290 - 财政年份:2023
- 资助金额:
$ 15.72万 - 项目类别:
Outer Membrane Vesicles in Shiga Toxin-Mediated Inflammatory and Thrombotic Responses Leading to Systemic Disease
志贺毒素介导的导致全身性疾病的炎症和血栓反应中的外膜囊泡
- 批准号:
10668016 - 财政年份:2023
- 资助金额:
$ 15.72万 - 项目类别:
Enterovirus interference with rotavirus vaccine replication and immunity
肠道病毒干扰轮状病毒疫苗的复制和免疫
- 批准号:
10737392 - 财政年份:2023
- 资助金额:
$ 15.72万 - 项目类别:
Mast cell regulation of food allergen induced malaise through GDF15-GFRAL signaling
肥大细胞通过 GDF15-GFRAL 信号调节食物过敏原引起的不适
- 批准号:
10605915 - 财政年份:2023
- 资助金额:
$ 15.72万 - 项目类别:
Aim protein-based anti-inflammatory therapeutic for the treatment of IBD
基于蛋白质的抗炎疗法治疗 IBD
- 批准号:
10822016 - 财政年份:2023
- 资助金额:
$ 15.72万 - 项目类别:














{{item.name}}会员




